BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choi SJ, Kim JK, Hwang SD. Mesenchymal stem cell therapy for chronic renal failure. Expert Opin Biol Ther. 2010;10:1217-1226. [PMID: 20560782 DOI: 10.1517/14712598.2010.500284] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Quimby JM, Webb TL, Habenicht LM, Dow SW. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther 2013;4:48. [PMID: 23632128 DOI: 10.1186/scrt198] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 8.0] [Reference Citation Analysis]
2 Penn MS. SDF-1:CXCR4 axis is fundamental for tissue preservation and repair. Am J Pathol 2010;177:2166-8. [PMID: 20889567 DOI: 10.2353/ajpath.2010.100803] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
3 Tang D, Zhu H, Wu J, Chen H, Zhang Y, Zhao X, Chen X, Du W, Wang D, Lin X. Silencing myostatin gene by RNAi in sheep embryos. J Biotechnol. 2012;158:69-74. [PMID: 22285957 DOI: 10.1016/j.ypmed.2012.01.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
4 Lindoso RS, Collino F, Bruno S, Araujo DS, Sant'Anna JF, Tetta C, Provero P, Quesenberry PJ, Vieyra A, Einicker-Lamas M, Camussi G. Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury. Stem Cells Dev 2014;23:1809-19. [PMID: 24669934 DOI: 10.1089/scd.2013.0618] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 9.4] [Reference Citation Analysis]
5 Guo J, Zou Y, Wu Z, Wu W, Xu Z, Hu H, Huang L, Dong H, Chen J, Lu J, Fu Y, Wang J, Ma Y, Chen X, He F, Yang S, Liao L, Chen J, Zheng F, Tan J. Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms. Cytotherapy 2014;16:471-84. [PMID: 24119646 DOI: 10.1016/j.jcyt.2013.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 van Koppen A, Joles JA, van Balkom BW, Lim SK, de Kleijn D, Giles RH, Verhaar MC. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One 2012;7:e38746. [PMID: 22723882 DOI: 10.1371/journal.pone.0038746] [Cited by in Crossref: 132] [Cited by in F6Publishing: 125] [Article Influence: 13.2] [Reference Citation Analysis]
7 Kouchakian MR, Baghban N, Moniri SF, Baghban M, Bakhshalizadeh S, Najafzadeh V, Safaei Z, Izanlou S, Khoradmehr A, Nabipour I, Shirazi R, Tamadon A. The Clinical Trials of Mesenchymal Stromal Cells Therapy. Stem Cells Int 2021;2021:1634782. [PMID: 34745268 DOI: 10.1155/2021/1634782] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Urt-Filho A, Oliveira RJ, Hermeto LC, Pesarini JR, David Nd, Cantero Wde B, Falcão G, Marks G, Antoniolli-Silva AC. Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model. Genet Mol Biol 2016;39:290-9. [PMID: 27275667 DOI: 10.1590/1678-4685-GMB-2015-0178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
9 Hyun YY, Kim IO, Kim MH, Nam DH, Lee MH, Kim JE, Song HK, Cha JJ, Kang YS, Lee JE, Kim HW, Han JY, Cha DR. Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy. Cell Transplant 2012;21:2425-39. [PMID: 22525004 DOI: 10.3727/096368912X639008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
10 Wang Y, Lu X, He J, Zhao W. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease. Stem Cell Res Ther 2015;6:100. [PMID: 25998259 DOI: 10.1186/s13287-015-0095-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
11 Zhang H, Chen Z, Bie P. Bone marrow-derived mesenchymal stem cells as immunosuppressants in liver transplantation: a review of current data. Transfus Med Rev 2012;26:129-41. [PMID: 22015073 DOI: 10.1016/j.tmrv.2011.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
12 Otto WR, Wright NA. Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair. 2011;4:20. [PMID: 21902837 DOI: 10.1186/1755-1536-4-20] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 7.4] [Reference Citation Analysis]
13 Lira R, Oliveira M, Martins M, Silva C, Carvalho S, Stumbo AC, Cortez E, Verdoorn K, Einicker-lamas M, Thole A, de Carvalho L. Transplantation of bone marrow-derived MSCs improves renal function and Na++K+-ATPase activity in rats with renovascular hypertension. Cell Tissue Res 2017;369:287-301. [DOI: 10.1007/s00441-017-2602-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
14 Han YS, Kim SM, Lee JH, Lee SH. Co-Administration of Melatonin Effectively Enhances the Therapeutic Effects of Pioglitazone on Mesenchymal Stem Cells Undergoing Indoxyl Sulfate-Induced Senescence through Modulation of Cellular Prion Protein Expression. Int J Mol Sci 2018;19:E1367. [PMID: 29734669 DOI: 10.3390/ijms19051367] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 da Silva AF, Silva K, Reis LA, Teixeira VP, Schor N. Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction. Cell Transplant 2015;24:2657-66. [PMID: 25695732 DOI: 10.3727/096368915X687534] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
16 Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, Camussi G. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011;26:1474-1483. [PMID: 21324974 DOI: 10.1093/ndt/gfr015] [Cited by in Crossref: 518] [Cited by in F6Publishing: 497] [Article Influence: 47.1] [Reference Citation Analysis]
17 Kostyuk SV, Proskurnina EV, Ershova ES, Kameneva LV, Malinovskaya EM, Savinova EA, Sergeeva VA, Umriukhin PE, Dolgikh OA, Khakina EA, Kraevaya OA, Troshin PA, Kutsev SI, Veiko NN. The Phosphonate Derivative of C60 Fullerene Induces Differentiation towards the Myogenic Lineage in Human Adipose-Derived Mesenchymal Stem Cells. Int J Mol Sci 2021;22:9284. [PMID: 34502190 DOI: 10.3390/ijms22179284] [Reference Citation Analysis]
18 Ma H, Wu Y, Zhang W, Dai Y, Li F, Xu Y, Wang Y, Tu H, Li W, Zhang X. The effect of mesenchymal stromal cells on doxorubicin-induced nephropathy in rats. Cytotherapy 2013;15:703-11. [DOI: 10.1016/j.jcyt.2013.02.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
19 Akan E, Cetinkaya B, Kipmen-Korgun D, Ozmen A, Koksoy S, Mendilcioğlu İ, Sakinci M, Suleymanlar G, Korgun ET. Effects of amnion derived mesenchymal stem cells on fibrosis in a 5/6 nephrectomy model in rats. Biotech Histochem 2021;:1-14. [PMID: 33522283 DOI: 10.1080/10520295.2021.1875502] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Caldas HC, Hayashi AP, Abbud-Filho M. Repairing the chronic damaged kidney: the role of regenerative medicine. Transplant Proc 2011;43:3573-6. [PMID: 22172807 DOI: 10.1016/j.transproceed.2011.10.053] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
21 Wong CY. Current advances of stem cell-based therapy for kidney diseases. World J Stem Cells 2021; 13(7): 914-933 [PMID: 34367484 DOI: 10.4252/wjsc.v13.i7.914] [Reference Citation Analysis]
22 Gad AM, Hassan WA, Fikry EM. Significant curative functions of the mesenchymal stem cells on methotrexate-induced kidney and liver injuries in rats. J Biochem Mol Toxicol 2017;31:e21919. [DOI: 10.1002/jbt.21919] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
23 Yao K, Ricardo SD. Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease. Nephrology (Carlton) 2016;21:363-71. [PMID: 26437381 DOI: 10.1111/nep.12643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
24 Madariaga ML, Ott HC. Bioengineering kidneys for transplantation. Semin Nephrol 2014;34:384-93. [PMID: 25217267 DOI: 10.1016/j.semnephrol.2014.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
25 Ma H, Wu Y, Xu Y, Sun L, Zhang X. Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis. Am J Med Sci. 2013;346:486-493. [PMID: 23514668 DOI: 10.1097/maj.0b013e3182831777] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
26 Messina M, Gallo E, Mella A, Pagani F, Biancone L. Update on the treatment of focal segmental glomerulosclerosis in renal transplantation. World J Transplant 2016; 6(1): 54-68 [PMID: 27011905 DOI: 10.5500/wjt.v6.i1.54] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
27 Yang RC, Zhu XL, Wang J, Wan F, Zhang HQ, Lin Y, Tang XL, Zhu B. Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models. BMC Nephrol 2018;19:335. [PMID: 30466397 DOI: 10.1186/s12882-018-1137-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
28 Papazova DA, Oosterhuis NR, Gremmels H, van Koppen A, Joles JA, Verhaar MC. Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis. Dis Model Mech. 2015;8:281-293. [PMID: 25633980 DOI: 10.1242/dmm.017699] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 7.9] [Reference Citation Analysis]
29 Seifert M, Stolk M, Polenz D, Volk HD. Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection. Front Immunol. 2012;3:202. [PMID: 22826709 DOI: 10.3389/fimmu.2012.00202] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
30 Prunotto M, Budd DC, Gabbiani G, Meier M, Formentini I, Hartmann G, Pomposiello S, Moll S. Epithelial-mesenchymal crosstalk alteration in kidney fibrosis. J Pathol 2012;228:131-47. [PMID: 22570261 DOI: 10.1002/path.4049] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]